ESR2 and urinary bladder cancer: Potential downstream targets/pathways of ER signaling in bladder cancer cells were also identified and included ERK (activated by E2 [80]), AKT (via ERα [56]), and minichromosome maintenance complex component 5 (MCM5) involving the initiation of DNA replication (via ERβ [57]).